Key facts
- This page summarizes Poleg Tamir's Form 4 filing for Real REMAX Group Inc. (REAX).
- 2 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 14 Sep 2026, 16:05.
Poleg Tamir - 10 Sep 2026 Form 4 Insider Report for Real REMAX Group Inc. (REAX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- REAX
- Reported as of
- 10 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Sep 2026, 16:05:22 UTC
- Prior SEC filing
- 24 Aug 2026
- Next SEC filing
- 15 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexandra Lumpkin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Poleg Tamir filed Form 4 for Real REMAX Group Inc. (REAX) on 14 Sep 2026.
Change
- Previous filing in this sequence was filed on 24 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001919883
Primary reporting owner
Poleg Tamir
- Relationship
- Chief Executive Officer, Director
- Address
- C/O REAL REMAX GROUP INC., 701 BRICKELL AVE., 17TH FLOOR, MIAMI
- Signature
- /s/ Alexandra Lumpkin, Attorney-in-Fact
- Signature date
- 14 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
REAX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,102
- Change %
- +0.54%
- Price
- $0.000000*
- Shares after
- 762,232
- Date
- 10 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
REAX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -4,102
- Change %
- -9.1%
- Price
- $0.000000*
- Shares after
- 41,015
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,102
- Exercise price
- Footnotes
- F3, F5, F6
REAX
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 107,057
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 107,057
- Exercise price
- $1.99
- Footnotes
- F2
REAX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 20,000
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $10.13
- Footnotes
- F2
REAX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 399,999
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 399,999
- Exercise price
- $15.40
- Footnotes
- F2
REAX
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 37,743
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 37,743
- Exercise price
- Footnotes
- F3, F4
REAX
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 148,377
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 148,377
- Exercise price
- Footnotes
- F3, F7
REAX
holding
Derivative
Performance Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 28,764
- Date
- 10 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,764
- Exercise price
- Footnotes
- F8, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
The Reporting Person previously reported awards of restricted stock units ("RSUs") and performance restricted stock units ("PSUs") in Table 1 of Form 3. This amount reflects the exclusion of the RSUs and PSUs.
Footnote F2
These stock options are fully vested and exercisable.
Footnote F3
Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Footnote F4
These RSUs vest in accordance with the following schedule: approximately 5,392 shares will vest quarterly from September 13, 2026 through March 13, 2028.
Footnote F5
Reflects 4,102 RSUs that vested on September 10, 2026.
Footnote F6
These RSUs vest in accordance with the following schedule: 4,102 shares will vest quarterly starting on September 10, 2026 through March 10, 2028; and approximately 4,101 shares will vest quarterly starting June 10, 2028 through March 10, 2029.
Footnote F7
These RSUs vest in accordance with the following schedule: 37,093 will vest on March 15, 2027; 9,274 will vest quarterly starting on June 15, 2027 through March 15, 2029; and 9,273 will vest quarterly starting on June 15, 2029 through March 15, 2030.
Footnote F8
Each PSU represents a contingent right to receive one share of Common Stock of the Issuer.
Footnote F9
These PSUs will be earned based upon the Issuer's performance during the performance period. Once earned, the PSUs will vest in accordance with the following schedule: one-quarter of the PSUs will vest on March 15, 2027 and the remaining shares will vest quarterly over the next four quarters immediately following March 15, 2027.